Biosimilars are a cost effective alternative to biological therapies and can eventually lead to potential budget savings and provide improved access to life-changing treatment for patients.
But he said he was concerned about the government's review being linked to an ongoing and increasingly pressurised agenda to cut red and green tape and achieve budget savings.
Modelling on the likely effects on fees, university revenue and the government's budget suggests this policy has a good chance of achieving its aims while still making some budget savings.
